Re-excision of margins after breast cancer surgery

Why this page exists

You may be reading this because you have had a lumpectomy or wide local excision for breast cancer and have been told that the margin was involved — that cancer cells were seen at, or very close to, the edge of the tissue that was removed — and that a second operation is recommended.

This is one of the most common reasons for a second operation after breast-conserving surgery. It happens to a significant minority of patients across all UK practice and is not a sign that the original surgery was poorly done, nor that the cancer is more aggressive than first thought. It is, in most cases, a routine next step in the same treatment pathway.

This page explains what “involved margin” means, why it happens, what the re-excision operation involves, and what the alternatives are.

What “margin” means

When a cancer is removed at lumpectomy, the surgeon takes the cancer together with a rim of healthy-looking tissue around it. The pathologist then examines the removed tissue and measures the distance from the cancer to the edge of the specimen — the margin.

There are three possible findings on the pathologist’s report:

Clear margin — the cancer is at least a defined distance from the edge of the specimen. The convention in UK practice for invasive cancer is “no ink on tumour” — meaning cancer cells are not touching the inked edge of the specimen. For DCIS, a wider margin (typically 2 mm) is the convention.
Close margin — for invasive cancer, cancer cells within 1 mm of the inked edge but not touching it. Re-excision is considered (NICE NG101), weighing tumour biology and planned adjuvant treatment including radiotherapy. For DCIS without invasive cancer, re-excision is considered when tumour cells are within 2 mm of the edge.
Involved margin — cancer cells touching the inked edge (“tumour on ink”, 0 mm for invasive cancer). Re-excision is usually offered.

The margin assessment happens in the days after the operation, after the pathologist has examined the whole specimen. The result is reviewed at the multidisciplinary team (MDT) meeting before any further surgery is recommended.

Why involved margins happen

A lumpectomy is performed without the surgeon being able to see exactly where the cancer ends, particularly for diffuse or multifocal cancers. Several factors increase the chance that the margin comes back involved:

DCIS more often than invasive cancer extends microscopically beyond what is visible on imaging or felt on examination. Even with careful surgical technique, DCIS sometimes extends into normal-appearing tissue at the edge of the specimen.
Lobular invasive cancer, more than ductal cancer, tends to spread in a diffuse pattern that is harder to delineate on imaging.
Imaging-occult disease — small areas of cancer that did not show on the pre-operative mammogram, ultrasound, or MRI.
The tumour was close to a tissue plane (skin, muscle, fascia) where there is no further tissue to take, and the close margin is at that surface rather than in the breast itself. In these specific cases, re-excision is not always recommended.

Modern UK practice uses techniques that reduce the rate of involved margins — pre-operative imaging including MRI in selected cases, intraoperative specimen X-ray, and shaved margin techniques during surgery. Despite all of these, reoperation after breast-conserving surgery in UK NHS practice averages around 18–20%, with variation between centres (national audit data). Rates are higher for DCIS than for isolated invasive disease.

What the re-excision operation involves

A re-excision is usually a smaller operation than the original lumpectomy. The surgical principle is to take a further rim of tissue from the side of the original cavity where the margin was involved, leaving the rest of the breast undisturbed.

Approach:

The original incision is reopened (so no new scar is created).
The tissue from the side of the original cavity that was reported as involved is identified — sometimes guided by clips placed at the original operation, sometimes by the position of the original specimen.
A further few millimetres to a centimetre of tissue is taken from that side, then sent to pathology.
The cavity is closed and the incision repaired.

Anaesthetic and stay:

General anaesthetic.
Typically 30–60 minutes operating time.
Day-case in most cases.

What does it not change:

The cosmetic result of the original lumpectomy is largely preserved. A small additional volume of tissue is removed from one side, but the overall shape is kept as close as possible to the post-lumpectomy contour.
The sentinel lymph node biopsy (if it was done at the first operation) does not need to be repeated.
Adjuvant treatment plans — radiotherapy, chemotherapy, hormone therapy — are not changed by needing a re-excision.

What about a second re-excision?
A small percentage of re-excisions also come back with involved margins. The next decision (further re-excision vs. moving to mastectomy) depends on how much breast tissue remains, the pattern of disease, and the patient’s preference. This is reviewed at MDT.

When mastectomy is the recommended next step instead

In some cases, re-excision is not the right next operation, and mastectomy is recommended instead:

Multifocal involved margins — when several edges of the original specimen are positive, particularly with extensive DCIS, the disease pattern usually exceeds what re-excision can address.
Insufficient remaining breast tissue — particularly in smaller-breasted patients, where a re-excision would leave a poor cosmetic result and limited residual tissue.
Repeated involved margins — if a previous re-excision has already been done and the margin is still involved, mastectomy is usually the next step.
Patient preference — some patients, after one positive margin, prefer mastectomy to a further attempt at breast-conserving surgery, particularly if reconstruction has already been considered. This is a reasonable choice.

Where mastectomy is recommended, the conversation also includes reconstruction options, if not already discussed.

Recovery from re-excision

Recovery is generally easier than the original lumpectomy because the operation is smaller and the patient knows what to expect:

First few days — mild discomfort at the wound site, well controlled by paracetamol and ibuprofen. A supportive bra is comfortable.
First week — most patients are back to desk-based work within 2–3 days; physical work or heavy lifting waits a week or two.
Two weeks — most everyday activity resumed including driving and gentle exercise.
Six weeks — full activity resumed.

The recovery does not delay radiotherapy in most cases — radiotherapy is usually started 4–6 weeks after the most recent surgery, and a re-excision a few weeks after the original lumpectomy fits this timeline.

Common questions The questions patients ask first

Does an involved margin mean my cancer is more aggressive than originally thought?

No. The aggressiveness of a breast cancer is determined by its biology — the tumour grade, hormone-receptor status, HER2 status, and so on — not by whether the margins were clear at the first operation. An involved margin reflects how the cancer was distributed in the breast tissue, not how aggressive it is.

Could the original surgery have done more to avoid this?

Sometimes, but often not. The amount of normal-looking tissue taken at the original operation is a balance between completeness of excision and cosmetic outcome. Taking very large margins routinely would reduce the re-excision rate but at the cost of worse cosmetic results for the majority of patients who do have clear margins. Most experienced units accept a modest re-excision rate as part of standard practice, rather than over-treating most patients to avoid it.

Will I still need radiotherapy after re-excision?

Yes — radiotherapy is given after breast-conserving surgery (lumpectomy plus, where needed, re-excision) regardless of whether one or two operations were done. The re-excision is designed to fit into the radiotherapy timeline and rarely delays it.

Could I just have radiotherapy without a second operation?

For most patients with involved margins, the answer is no — radiotherapy is part of the treatment but does not substitute for clearing the margin surgically. There are occasional exceptions, particularly when the close margin is at a surface (such as the skin or chest wall) where there is no further tissue to take. These cases are decided at MDT.

Will I have a new scar?

No. The original incision is reopened for the re-excision, so no new scar is created. The original scar may end up slightly longer or slightly more tender for a few weeks; it usually heals to a similar end result.

How does this affect my insurance?

Re-excision is a recognised part of the cancer pathway and is covered by all major UK insurers. No new pre-authorisation is usually needed — the original treatment authorisation typically covers further surgery within the same episode of care. The PA will confirm with your insurer.

Will my reconstruction options change?

If you are having lumpectomy plus radiotherapy, reconstruction is not a routine part of the pathway. If the pathway changes to mastectomy after a failed re-excision, reconstruction options become part of the conversation — implant-based, autologous, or aesthetic flat closure. See the reconstruction pillar page.